No single GLP-1 is universally safestsafety depends on individual health status, comorbidities, and how your body processes GLP-1 receptor signaling
regarding marketing messages by text, phone, or email
During this phase, we stay in close contact
15 Phase II trials targeting MASH have shown that treatment with SEMA 0.4 mg daily for 72 weeks resulted in more patients with liver fibrosis stage F2/F3 achieving improvement in MASH without progression of liver fibrosis (odds ratio = 6.87, 95% CI = 2.6017.63) compared to placebo
Insurance Yes, for meds Concierge available How to Get Started Complete two quizzes about weight-loss goals and health history
Those exploring GLP-1 use during breastfeeding should consult their physician for any supplement decisions